Status : investigational


TNX-901 is a therapeutic monoclonal antibodies designed to address significant unmet medical needs in the areas of asthma, allergy, inflammation and other diseases affecting the human immune system.


Investigated for use/treatment in allergic reaction.

Mechanism Of Action

TNX-901 is an anti-IgE antibody. IgE antibody is the receptor responsible for allergic reactions and severe asthma attacks. An anti-IgE antibody binds IgE and prevents it from initiating an allergic reaction.

Chemical Classification

Calculated Property

kind Value Source

Target within organism

  • High affinity immunoglobulin epsilon receptor subunit alpha : in Human